Alle patienter fik methotrexat (optimeret til 20 mg/ uge ved uge 8) og enten placebo, 3 mg/ kg eller 6 mg/ kg infliximab i ugerne 0, 2 og 6 samt hver 8. uge derefter.
All patients received methotrexate (optimised to 20 mg/ wk by week 8) and either placebo, 3 mg/ kg or 6 mg/ kg infliximab at weeks 0, 2, and 6 and every 8 weeks thereafter.